"Designing Growth Strategies is in our DNA"

Liver Disease Diagnostics and Treatment Market Size, Share and Global Trend By Treatment ( Anti-Viral Drugs, Vaccines, Chemotherapy, Targeted Therapy, Immunosuppressant, Immunoglobulins), By Diagnosis (Imaging, mLaboratory Tests, Endoscopy, Biopsy, Others), By End User (Hospitals, Clinics, Diagnostic Laboratories, Others), and Geography Forecast till 2021-2028

Region : Global | Report ID: FBI101132 | Status : Ongoing

 

KEY MARKET INSIGHTS

The liver is a vital organ which mainly functions to metabolize and detoxify the toxic substances that could be harmful to the body. Liver disease refers to any disease condition that results in liver inflammation and may disturb the proper functioning of the liver. The causes for liver diseases are an infection, autoimmune diseases, overconsumption of over the counter drugs, injury, alcohol consumption, and others.

Liver disease includes liver cancer, hepatitis A, hepatitis B, Non-alcoholic fatty liver disease, cirrhosis, hemochromatosis, and many others. According to the American Cancer Society projections, the new cases of primary liver cancer and intrahepatic bile duct cancer in the United States for 2018 will be above 30,610 in males and 11,610 in females. Growing prevalence of hepatitis, A & B infections, growing obesity, and rising unmet clinical need in liver disease are likely to boost the growth of liver disease diagnostics and treatment market during the forecast period.

To gain extensive insights into the market, Request for Customization


The global liver disease diagnostics and treatment market growth is being driven by the increase in the prevalence of liver cancer, alcohol consumption, health reimbursement for liver cancer and heavy intake of over the counter high dosage drugs. Other factors which are likely to boost the growth of global liver disease diagnostics and treatment market are the presence of strong pipeline drugs for the treatment of fatty liver disease and growing key mergers and acquisitions among many key players.

For example, in October 2018, Novartis AG collaborated with Pfizer Inc., to initiate clinical study combining tropifexor, including an Acetyl CoA-Carboxylase (ACC) Inhibitor, and a Ketohexokinase (KHK) Inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).


However, side effects and risks associated with the usage of medications involved for the treatment of liver disease and the stringent government regulations are expected to hinder the growth in global liver disease diagnostics and treatment market during the forecast period.


 Key Players Covered


Some of the major companies that are present in the global liver disease diagnostics and treatment market report include Pfizer Inc., Novartis AG, Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Mylan N.V., among others.


SEGMENTATION


























SEGMENTATION


DETAILS

By Treatment



· Anti-Viral Drugs


· Vaccines


· Chemotherapy


· Targeted Therapy


· Immunosuppressant


· Immunoglobulins


· Others



By Diagnosis



· Imaging


· Laboratory Tests


· Endoscopy


· Biopsy


· Others



By End User



· Hospitals


· Clinics


· Diagnostic Laboratories


· Others



By Geography



· North America (U.S. and Canada)


· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)


· Latin America (Brazil, Mexico, and Rest of Latin America)


· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)



As per the global liver disease diagnostics and treatment market trends, imaging segment, among diagnosis segment, is anticipated to hold the largest share in global liver disease diagnostics and treatment market owing to the growing demand for non-invasive imaging techniques and growing technological advancements in liver disease imaging techniques.


Key Insights



  • Pipeline Analysis of Liver Disease Drugs

  • Overview of Epidemiology of Liver Cancer

  • The Regulatory Scenario of Key Country/Region

  • Recent Key Industry Developments – Mergers, Acquisitions, and Partnerships.


Regional Analysis


The global liver disease diagnostics and treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global liver disease diagnostics and treatment market owing to increasing adoption of novel diagnostic and therapeutic approaches for the treatment of liver disease, growing prevalence liver disease, and increase in the unmet need. Asia. Asia Pacific is anticipated to register significant CAGR in global liver disease diagnostics and treatment market during the forecast period owing to a growing patient population and growing investments in R&D by many key players & government organizations.


Liver Disease Diagnostics and Treatment Industry Developments 



  • In January 2019, SciCann Therapeutics launched a liver disease program in Tel Aviv University which was mainly designed to explore the efficacy of SciCann’s line of proprietary, cannabinoid-based, anti-inflammatory combination products for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
  • In October 2018, Novartis AG collaborated with Pfizer Inc., to initiate clinical study combining tropifexor, including an Acetyl CoA-Carboxylase (ACC) Inhibitor, and a Ketohexokinase (KHK) Inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).

Liver Disease Diagnostics and Treatment Market  Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Lek
Ipsos
Amgen
iqvia
Jubilant

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X